BAL 1198Alternative Names: Aerothricin 137; RO 0791198
Latest Information Update: 01 Jul 2003
At a glance
- Originator Basilea Pharmaceutica
- Class Antifungals; Depsipeptides
- Mechanism of Action Glucan synthase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Mycoses